-+ 0.00%
-+ 0.00%
-+ 0.00%

Bicara Therapeutics President, COO and interim CEO Ryan Cohlhepp disposes of common shares worth $400,049.15

PUBT·09/10/2026 20:23:44
Listen to the news
Bicara Therapeutics President, COO and interim CEO Ryan Cohlhepp disposes of common shares worth $400,049.15
  • Ryan Cohlhepp, president, COO, interim CEO, director, cut his Bicara stake to 181,641 common shares on Sep. 8, 2026.
  • Disposed of 17,500 shares at USD 3.79 via option exercise, then sold 17,500 shares at weighted-average prices of USD 22.77, USD 23.43.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bicara Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001470831-26-000883), on September 10, 2026, and is solely responsible for the information contained therein.